SDGR Schrodinger, Inc.
$26.72▲ +9.06%
Healthcare
Other
After hours
$27.00▲ +1.05%
Oct 27, 4:41 PM ET
Volume 1.52M
Avg Volume (10D) 1.56M
Key Metrics & Fundamentals
Market Cap
$2.00B
P/E Ratio
–
Div Yield
0.00%
52W Range
10.95 - 33.78
% vs 50 MA
9.78%
% vs 200 MA
61.03%
RSI-14
55.0
MACD Histogram
-0.2700
Beta (1Y vs SPY)
1.65
Free Cash Flow
-$34.43M
Gross Rev
$58.89M
Gross Profit
$32.43M
EBITDA
-$85.93M
COGS
$26.46M
Operating Exp
$73.98M
Operating Income
-$41.55M
EBIT
-$41.55M
Pretax Income
$7.35M
Net Income
$5.98M
EPS (Diluted)
0.08
Price & Volume History
Loading chart…
Recent News
Schrödinger Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business Wire · Oct 26, 2026 8:30 AM ET
Schrödinger to Announce Third Quarter 2026 Financial Results on November 4
Business Wire · Oct 21, 2026 8:30 AM ET
UBS Adjusts Schrodinger Price Target to $21 From $19, Maintains Neutral Rating
MT Newswires · Oct 20, 2026 10:09 AM ET
Schrödinger Research Published in Nature Reveals New Insights into Lithium-Ion Battery Chemistry
Business Wire · Oct 14, 2026 11:05 AM ET
Schrödinger (SDGR) Stock Fair Value Edges Higher As Analyst Views Split On AI Growth
Simply Wall St. · Oct 13, 2026 10:13 PM ET
What Could Go Wrong With Recursion Pharmaceuticals Stock?
Trefis · Oct 8, 2026 7:58 PM ET
Schrodinger (SDGR) Surges 7.6%: Is This an Indication of Further Gains?
Zacks · Oct 6, 2026 6:38 AM ET
Schrödinger (SDGR) Could Be 29% Below Fair Value Despite A 38% Overvalued View
Simply Wall St. · Sep 27, 2026 4:05 PM ET
Can Recursion Pharmaceuticals' Strategic Deals Fuel Long-Term Growth?
Zacks · Sep 24, 2026 11:08 AM ET
Schrodinger Stock Has Technical Strength as It Hits New 2-Year Highs
Barchart · Sep 23, 2026 1:50 PM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See SDGR's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.